Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
Indicator | Company | Industry |
---|---|---|
-12.77 | -0.57 | |
P/BV (LTM)
Shows the ratio of the market price of the share to the current book value. มากกว่า |
4.40 | 1.11 |
EV/EBITDA (LTM)
Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months. มากกว่า |
-14.37 | 0.12 |
Net Debt/EBITDA (LTM)
A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt. มากกว่า |
1.72 | 0.34 |
-34.42 | -18.24 |
10x Genomics (TXG) stocks are traded on NASDAQ.
The stock ticker of 10x Genomics’s stocks or in other words, the code is TXG. The stocks are currently listed on the NASDAQ exchange.
According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, 10x Genomics (TXG) belongs to the «Healthcare» sector and the «Biotechnology» industry.
10x Genomics (TXG) stocks are traded on the NASDAQ exchange in dollars.
The current price of 10x Genomics stocks on 06.05.2024 is 27.48 dollars. per share.
10x Genomics (TXG) quotes have increased by -49.39% from the beginning of the year up to 27.48 dollars. per 1 stocks.
This month 10x Genomics (TXG) quotes have increased by 2.08% to 27.48 dollars. per share.
Today, on October, 06.05.2024 10x Genomics’s (TXG) stocks cost 27.48 dollars..
Capitalization is the market value of 10x Genomics (TXG) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 06.05.2024, the market capitalization of 10x Genomics (TXG) is estimated at about 3258186096 dollars.